Pfizer Inc PFE:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/28/23 EST
43.89quote price arrow up+0.10 (+0.23%)
Volume
2,002,893
Close
43.79quote price arrow down-0.46 (-1.04%)
Volume
21,601,111
52 week range
41.44 - 56.32
Loading...
  • Open44.22
  • Day High44.34
  • Day Low43.78
  • Prev Close44.25
  • 52 Week High56.32
  • 52 Week High Date04/11/22
  • 52 Week Low41.44
  • 52 Week Low Date10/11/22

Key Stats

  • Market Cap245.807B
  • Shares Out5.61B
  • 10 Day Average Volume25.47M
  • Dividend1.64
  • Dividend Yield3.75%
  • Beta0.63
  • YTD % Change-14.54

KEY STATS

  • Open44.22
  • Day High44.34
  • Day Low43.78
  • Prev Close44.25
  • 52 Week High56.32
  • 52 Week High Date04/11/22
  • 52 Week Low41.44
  • 52 Week Low Date10/11/22
  • Market Cap245.807B
  • Shares Out5.61B
  • 10 Day Average Volume25.47M
  • Dividend1.64
  • Dividend Yield3.75%
  • Beta0.63
  • YTD % Change-14.54

RATIOS/PROFITABILITY

  • EPS (TTM)5.27
  • P/E (TTM)8.31
  • Fwd P/E (NTM)10.41
  • EBITDA (TTM)42.501B
  • ROE (TTM)35.91%
  • Revenue (TTM)99.676B
  • Gross Margin (TTM)65.51%
  • Net Margin (TTM)30.35%
  • Debt To Equity (MRQ)39.59%

EVENTS

  • Earnings Date01/31/2023
  • Ex Div Date01/26/2023
  • Div Amount0.41
  • Split Date-
  • Split Factor-

Related Video

Thursday, Jan. 26, 2023: Cramer says buy this stock whenever you get the chance
VIDEO10:0010:00
CNBC Investing ClubThursday, Jan. 26, 2023: Cramer says buy this stock whenever you get the chance

Profile

MORE
Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global...
Albert Bourla Ph.D.
Chairman of the Board, Chief Executive Officer
David Denton
Executive Vice President, Chief Financial Officer
Aamir Malik
Executive Vice President, Chief Business Innovation Officer
Lidia Fonseca Ph.D.
Executive Vice President, Chief Digital and Technology Officer
Douglas Lankler
Executive Vice President, General Counsel
Address
235 E 42ND ST
New York, NY
10017-5703
United States

Top Peers

SYMBOLLASTCHG%CHG
RHHBY
Roche Holding AG
39.29-0.09-0.23%